Literature DB >> 27196580

Comparative genomics of Crohn's disease-associated adherent-invasive Escherichia coli.

Claire L O'Brien1,2, Marie-Agnès Bringer3,4, Kathryn E Holt5, David M Gordon6, Anaëlle L Dubois4, Nicolas Barnich4, Arlette Darfeuille-Michaud4, Paul Pavli1,2.   

Abstract

OBJECTIVE: Adherent-invasive Escherichia coli (AIEC) are a leading candidate bacterial trigger for Crohn's disease (CD). The AIEC pathovar is defined by in vitro cell-line assays examining specific bacteria/cell interactions. No molecular marker exists for their identification. Our aim was to identify a molecular property common to the AIEC phenotype.
DESIGN: 41 B2 phylogroup E. coli strains were isolated from 36 Australian subjects: 19 patients with IBD and 17 without. Adherence/invasion assays were conducted using the I-407 epithelial cell line and survival/replication assays using the THP-1 macrophage cell line. Cytokine secretion tumour necrosis factor ((TNF)-α, interleukin (IL) 6, IL-8 and IL-10) was measured using ELISA. The genomes were assembled and annotated, and cluster analysis performed using CD-HIT. The resulting matrices were analysed to identify genes unique/more frequent in AIEC strains compared with non-AIEC strains. Base composition differences and clustered regularly interspaced palindromic repeat (CRISPR) analyses were conducted.
RESULTS: Of all B2 phylogroup strains assessed, 79% could survive and replicate in macrophages. Among them, 11/41 strains (5 CD, 2 UCs, 5 non-IBD) also adhere to and invade epithelial cells, a phenotype assigning them to the AIEC pathovar. The AIEC strains were phylogenetically heterogeneous. We did not identify a gene (or nucleic acid base composition differences) common to all, or the majority of, AIEC. Cytokine secretion and CRISPRs were not associated with the AIEC phenotype.
CONCLUSIONS: Comparative genomic analysis of AIEC and non-AIEC strains did not identify a molecular property exclusive to the AIEC phenotype. We recommend a broader approach to the identification of the bacteria-host interactions that are important in the pathogenesis of Crohn's disease. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  CROHN'S DISEASE; ENTERIC BACTERIAL MICROFLORA; INTESTINAL MICROBIOLOGY

Mesh:

Substances:

Year:  2016        PMID: 27196580     DOI: 10.1136/gutjnl-2015-311059

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  31 in total

Review 1.  The population genetics of pathogenic Escherichia coli.

Authors:  Erick Denamur; Olivier Clermont; Stéphane Bonacorsi; David Gordon
Journal:  Nat Rev Microbiol       Date:  2020-08-21       Impact factor: 60.633

2.  Adaptation of adherent-invasive E. coli to gut environment: Impact on flagellum expression and bacterial colonization ability.

Authors:  Gwladys Sevrin; Sébastien Massier; Benoit Chassaing; Allison Agus; Julien Delmas; Jérémy Denizot; Elisabeth Billard; Nicolas Barnich
Journal:  Gut Microbes       Date:  2018-03-01

3.  Exosomes transfer miRNAs from cell-to-cell to inhibit autophagy during infection with Crohn's disease-associated adherent-invasive E. coli.

Authors:  Anaïs Larabi; Guillaume Dalmasso; Julien Delmas; Nicolas Barnich; Hang Thi Thu Nguyen
Journal:  Gut Microbes       Date:  2020-06-25

4.  Phylogenetic background and habitat drive the genetic diversification of Escherichia coli.

Authors:  Marie Touchon; Amandine Perrin; Jorge André Moura de Sousa; Belinda Vangchhia; Samantha Burn; Claire L O'Brien; Erick Denamur; David Gordon; Eduardo Pc Rocha
Journal:  PLoS Genet       Date:  2020-06-12       Impact factor: 5.917

5.  Adherent-invasive E. coli metabolism of propanediol in Crohn's disease regulates phagocytes to drive intestinal inflammation.

Authors:  Monica Viladomiu; Maeva L Metz; Svetlana F Lima; Wen-Bing Jin; Lance Chou; Chun-Jun Guo; Gretchen E Diehl; Kenneth W Simpson; Ellen J Scherl; Randy S Longman
Journal:  Cell Host Microbe       Date:  2021-02-03       Impact factor: 21.023

Review 6.  Are Escherichia coli Pathotypes Still Relevant in the Era of Whole-Genome Sequencing?

Authors:  Roy M Robins-Browne; Kathryn E Holt; Danielle J Ingle; Dianna M Hocking; Ji Yang; Marija Tauschek
Journal:  Front Cell Infect Microbiol       Date:  2016-11-18       Impact factor: 5.293

7.  Genetic Diversity and Virulence Determinants of Escherichia coli Strains Isolated from Patients with Crohn's Disease in Spain and Chile.

Authors:  Sandra Céspedes; Waleska Saitz; Felipe Del Canto; Marjorie De la Fuente; Rodrigo Quera; Marcela Hermoso; Rául Muñoz; Daniel Ginard; Sam Khorrami; Jorge Girón; Rodrigo Assar; Ramón Rosselló-Mora; Roberto M Vidal
Journal:  Front Microbiol       Date:  2017-05-24       Impact factor: 5.640

8.  Diversity and Adaptations of Escherichia coli Strains: Exploring the Intestinal Community in Crohn's Disease Patients and Healthy Individuals.

Authors:  Maria N Siniagina; Maria I Markelova; Eugenia A Boulygina; Alexander V Laikov; Dilyara R Khusnutdinova; Sayar R Abdulkhakov; Natalia A Danilova; Alfiya H Odintsova; Rustam A Abdulkhakov; Tatyana V Grigoryeva
Journal:  Microorganisms       Date:  2021-06-15

9.  Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.

Authors:  Xin Fang; Jonathan M Monk; Nathan Mih; Bin Du; Anand V Sastry; Erol Kavvas; Yara Seif; Larry Smarr; Bernhard O Palsson
Journal:  BMC Syst Biol       Date:  2018-06-11

10.  Glucocorticoids Impair Phagocytosis and Inflammatory Response Against Crohn's Disease-Associated Adherent-Invasive Escherichia coli.

Authors:  Mauricio Javier Olivares-Morales; Marjorie Katherine De La Fuente; Karen Dubois-Camacho; Daniela Parada; David Diaz-Jiménez; Alejandro Torres-Riquelme; Xiaojiang Xu; Nayaret Chamorro-Veloso; Rodrigo Naves; Maria-Julieta Gonzalez; Rodrigo Quera; Carolina Figueroa; John Anthony Cidlowski; Roberto Mauricio Vidal; Marcela Alejandra Hermoso
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.